Neuroimmune dysregulation in Alzheimer's disease: Mechanisms and therapeutic strategies

Key Points

• Neuroimmune dysregulation in Alzheimer's disease contributes significantly to cognitive decline, emphasizing the need for intervention.
• A focus on immune pathways may lead to new therapeutic strategies, potentially improving Alzheimer’s disease outcomes.
• Assessment of neuroinflammation and immune biomarkers helps identify mechanisms driving disease progression in Alzheimer's.
• These findings support further exploration of immunomodulatory treatments to mitigate cognitive effects in Alzheimer's patients.